Homeindia Newsindividual alertness discipline big strength in fight against omicron variant of covid 19 pm narendra modi 11933202.htm

    Individual alertness, discipline 'big strength' in fight against Omicron variant of COVID-19: PM Modi

    Individual alertness, discipline 'big strength' in fight against Omicron variant of COVID-19: PM Modi

    Individual alertness, discipline 'big strength' in fight against Omicron variant of COVID-19: PM Modi
    Profile image

    By CNBCTV18.com  IST (Updated)

    Mini

    In his Mann Ki Baat radio programme, PM Narendra Modi said India has achieved "unprecedented feat" in its inoculation drive but cautioned against Omicron variant of COVID-19

    Prime Minister Narendra Modi on Sunday said individual alertness and discipline are a big strength of the country in the fight against the Omicron variant of coronavirus.
    In his Mann Ki Baat radio programme, Modi said India has achieved "unprecedented feat" in its inoculation drive but cautioned against the new variant of the virus.
    "This new Omicron variant is being constantly reviewed by our scientists. Every day they are getting new data and steps are being taken based on their suggestions,"
    "We must remember that a new variant of COVID19 Omicron has knocked our doors. To defeat this global pandemic our effort as citizens is important," he said.
    Modi on Saturday had announced that vaccination against COVID-19 for children between 15 and 18 years will start from January 3, while "precaution dose" for healthcare and frontline workers would be administered from January 10.
    He had also said the precaution dose will also be available for citizens above 60 years of age and those with comorbidities on the advice of their doctor from January 10 next year.
    The gap between the second dose of COVID-19 vaccine and the third, which is being called a "precaution dose", is likely to be nine to 12 months, official sources said on Sunday. The nitty-gritty of the gaps for the vaccines currently being used in India's inoculation programme Covishield and Covaxin is being worked out, and a final decision over this will be taken soon, they said.
    (With inputs from PTI)
    arrow down

      Market Movers

      View All
      CompanyPriceChng%Chng